Literature DB >> 31767706

Thrombotic thrombocytopenic purpura masquerading as a stroke in a young man.

Christopher James Doig1, Louis Girard2, Deirdre Jenkins2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31767706      PMCID： PMC6877355          DOI： 10.1503/cmaj.190981

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.

Authors:  Marie Scully; Spero R Cataland; Flora Peyvandi; Paul Coppo; Paul Knöbl; Johanna A Kremer Hovinga; Ara Metjian; Javier de la Rubia; Katerina Pavenski; Filip Callewaert; Debjit Biswas; Hilde De Winter; Robert K Zeldin
Journal:  N Engl J Med       Date:  2019-01-09       Impact factor: 91.245

Review 2.  Thrombotic microangiopathies: a general approach to diagnosis and management.

Authors:  Donald M Arnold; Christopher J Patriquin; Ishac Nazy
Journal:  CMAJ       Date:  2016-10-17       Impact factor: 8.262

3.  Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.

Authors:  Evaren E Page; Johanna A Kremer Hovinga; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Blood       Date:  2016-04-08       Impact factor: 22.113

4.  Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.

Authors:  Y Benhamou; P-Y Boelle; B Baudin; S Ederhy; J Gras; L Galicier; E Azoulay; F Provôt; E Maury; F Pène; J-P Mira; A Wynckel; C Presne; P Poullin; J-M Halimi; Y Delmas; T Kanouni; A Seguin; C Mousson; A Servais; D Bordessoule; P Perez; M Hamidou; A Cohen; A Veyradier; P Coppo
Journal:  J Thromb Haemost       Date:  2014-12-18       Impact factor: 5.824

5.  Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

Authors:  G A Rock; K H Shumak; N A Buskard; V S Blanchette; J G Kelton; R C Nair; R A Spasoff
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

Review 6.  Thrombotic thrombocytopenic purpura.

Authors:  Bérangère S Joly; Paul Coppo; Agnès Veyradier
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

7.  Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura.

Authors:  Helen Yarranton; Hannah Cohen; Sue R Pavord; Sylvia Benjamin; Diana Hagger; Samuel J Machin
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

Review 8.  Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.

Authors:  Lucy C Fox; Solomon J Cohney; Joshua Y Kausman; Jake Shortt; Peter D Hughes; Erica M Wood; Nicole M Isbel; Theo de Malmanche; Anne Durkan; Pravin Hissaria; Piers Blombery; Thomas D Barbour
Journal:  Intern Med J       Date:  2018-06       Impact factor: 2.048

9.  Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.

Authors:  Marie Scully; Beverley J Hunt; Sylvia Benjamin; Ri Liesner; Peter Rose; Flora Peyvandi; Betty Cheung; Samuel J Machin
Journal:  Br J Haematol       Date:  2012-05-25       Impact factor: 6.998

10.  Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.

Authors:  Dineke Westra; Elena B Volokhina; Renate G van der Molen; Thea J A M van der Velden; Annelies Jeronimus-Klaasen; Joop Goertz; Valentina Gracchi; Eiske M Dorresteijn; Antonia H M Bouts; Mandy G Keijzer-Veen; Joanna A E van Wijk; Jaap A Bakker; Anja Roos; Lambert P van den Heuvel; Nicole C A J van de Kar
Journal:  Pediatr Nephrol       Date:  2016-10-07       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.